Inventor
DZIERBA CAROLYN DIANE
US29 patents
⚠️ This page may combine multiple inventors who share the name “DZIERBA CAROLYN DIANE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
26 patentsUS9902722B2Feb 27, 2018
Biaryl kinase inhibitors
BRISTOL MYERS SQUIBB CO19 citations94
US10155760B2Dec 18, 2018
Biaryl kinase inhibitors
BRISTOL MYERS SQUIBB CO3 citations84
US10913738B2Feb 9, 2021
Aminotriazolopyridines as kinase inhibitors
BRISTOL MYERS SQUIBB CO7 citations83
US10723734B2Jul 28, 2020
Biaryl kinase inhibitors
BRISTOL MYERS SQUIBB CO2 citations73
US10253027B2Apr 9, 2019
Aryl lactam kinase inhibitors
BRISTOL MYERS SQUIBB CO3 citations72
US9708337B2Jul 18, 2017
Aryl amide-based kinase inhibitors
BRISTOL MYERS SQUIBB CO3 citations72
US11767322B2Sep 26, 2023
Triazolopyridinyl compounds as kinase inhibitors
BRISTOL MYERS SQUIBB CO3 citations70
US12157733B2Dec 3, 2024
Aminotriazolopyridines as kinase inhibitors
BRISTOL MYERS SQUIBB CO0 citations62
US12065437B2Aug 20, 2024
Biaryl kinase inhibitors
BRISTOL MYERS SQUIBB CO0 citations62
US11440913B2Sep 13, 2022
Aminoimidazopyridazines as kinase inhibitors
BRISTOL MYERS SQUIBB CO2 citations62
US10981910B2Apr 20, 2021
Biaryl kinase inhibitors
BRISTOL MYERS SQUIBB CO0 citations62
US10544120B2Jan 28, 2020
Biaryl kinase inhibitors
BRISTOL MYERS SQUIBB CO2 citations62
US10246469B2Apr 2, 2019
Biaryl kinase inhibitors
BRISTOL MYERS SQUIBB CO1 citations62
US12110290B2Oct 8, 2024
Triazolopyridinyl compounds as kinase inhibitors
BRISTOL MYERS SQUIBB CO0 citations61
US7067658B2Jun 27, 2006
Pyridino and pyrimidino pyrazinones
BRISTOL MYERS SQUIBB CO6 citations55
US12275721B2Apr 15, 2025
Indazole carboxamides as kinase inhibitors
BRISTOL MYERS SQUIBB CO0 citations52
US12172975B2Dec 24, 2024
1H-indazole carboxamides as receptor-interacting protein kinase 1 inhibitors (RIPK1)
BRISTOL MYERS SQUIBB CO0 citations52
US12084426B2Sep 10, 2024
Indazole carboxamides as kinase inhibitors
BRISTOL MYERS SQUIBB CO0 citations51
US11618753B2Apr 4, 2023
Aminopyrrolotriazines as kinase inhibitors
BRISTOL MYERS SQUIBB CO0 citations51
US9932320B2Apr 3, 2018
Quinoline-based kinase inhibitors
BRISTOL MYERS SQUIBB CO1 citations51
US8969564B2Mar 3, 2015
Aryl ether-base kinase inhibitors
BRISTOL MYERS SQUIBB CO0 citations51
US8901305B2Dec 2, 2014
Aryl lactam kinase inhibitors
BRISTOL MYERS SQUIBB CO1 citations51
US8703953B2Apr 22, 2014
Aryl ether-base kinase inhibitors
BRISTOL MYERS SQUIBB CO1 citations51
US10035777B2Jul 31, 2018
Heterocyclic kinase inhibitors
BRISTOL MYERS SQUIBB CO0 citations41
US9737542B2Aug 22, 2017
Pyrrolotriazine kinase inhibitors
BRISTOL MYERS SQUIBB CO0 citations41
US10174044B2Jan 8, 2019
Fused pyridines as kinase inhibitors
BRISTOL MYERS SQUIBB CO0 citations37